Zouboulis CC, Passeron T, Pariser D, Wozniak MB, et al. Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials. Br J Dermatol 2024;190:836-845.
PMID: 38470171